HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Goldhirsch Selected Research

Neoplasm Metastasis (Metastasis)

10/2013High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.
2/2012Breast cancer subtypes and outcome after local and regional relapse.
10/2011Should liver metastases of breast cancer be biopsied to improve treatment choice?
6/2011Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.
10/2009The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.
1/2007Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00).
10/2006Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
10/2005Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.
11/2001Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
3/2001High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Goldhirsch Research Topics

Disease

114Breast Neoplasms (Breast Cancer)
01/2023 - 01/2000
51Neoplasms (Cancer)
10/2022 - 02/2000
11Neoplasm Metastasis (Metastasis)
10/2013 - 12/2000
3Disease Progression
01/2017 - 02/2001
3Carcinoma (Carcinomatosis)
04/2016 - 03/2000
3Stomach Neoplasms (Stomach Cancer)
04/2016 - 03/2000
3Lymphoma (Lymphomas)
02/2007 - 06/2001
2Noninfiltrating Intraductal Carcinoma (DCIS)
04/2015 - 12/2003
2Residual Neoplasm
02/2015 - 09/2005
2Triple Negative Breast Neoplasms
02/2012 - 01/2011
2Osteonecrosis (Kienbock's Disease)
01/2008 - 10/2006
2Adenocarcinoma
07/2004 - 01/2001
2Venous Thrombosis (Deep-Vein Thrombosis)
04/2004 - 01/2001
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2001 - 07/2000
2Cardiotoxicity
08/2000 - 06/2000
2Febrile Neutropenia
08/2000 - 03/2000
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
10/2022
1Amenorrhea
09/2017
1Primary Ovarian Insufficiency
08/2015
1Arthralgia (Joint Pain)
01/2014
1Myalgia
01/2014
1Fatigue
05/2012
1Hypersensitivity (Allergy)
03/2012
1Testicular Neoplasms (Testicular Cancer)
01/2011
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2009
1Osteoporosis
09/2009
1Bone Fractures (Bone Fracture)
09/2009
1Melanoma (Melanoma, Malignant)
01/2009

Drug/Important Bio-Agent (IBA)

20TamoxifenFDA LinkGeneric
12/2015 - 04/2000
18Fluorouracil (Carac)FDA LinkGeneric
04/2016 - 01/2000
18Estrogen ReceptorsIBA
03/2013 - 02/2000
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2012 - 04/2000
13Vinorelbine (Navelbine)FDA LinkGeneric
09/2009 - 01/2000
12Hormones (Hormone)IBA
01/2023 - 08/2000
12Progesterone Receptors (Progesterone Receptor)IBA
03/2013 - 08/2000
11AnthracyclinesIBA
08/2015 - 08/2000
11Methotrexate (Mexate)FDA LinkGeneric
02/2012 - 04/2000
10Cisplatin (Platino)FDA LinkGeneric
04/2016 - 01/2000
9Letrozole (Femara)FDA LinkGeneric
10/2021 - 09/2006
8human ERBB2 proteinIBA
04/2015 - 12/2007
8Taxoids (Taxanes)IBA
03/2012 - 06/2000
7Trastuzumab (Herceptin)FDA Link
12/2017 - 10/2005
7Docetaxel (Taxotere)FDA Link
04/2016 - 03/2000
5Phenobarbital (Luminal)FDA Link
03/2013 - 10/2010
4Estrogens (Estrogen)FDA Link
10/2021 - 08/2000
4Paclitaxel (Taxol)FDA LinkGeneric
08/2015 - 07/2000
4Biomarkers (Surrogate Marker)IBA
07/2013 - 11/2004
4Aromatase InhibitorsIBA
10/2011 - 01/2007
4Capecitabine (Xeloda)FDA Link
09/2009 - 12/2004
4SteroidsIBA
07/2005 - 06/2000
3Triptorelin Pamoate (Trelstar)FDA Link
09/2017 - 09/2006
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2017 - 09/2007
3Diphosphonates (Bisphosphonates)IBA
01/2008 - 12/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2006 - 01/2002
2ErbB Receptors (EGF Receptor)IBA
01/2023 - 04/2015
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2022 - 02/2012
2N,N'-bis(4-azidobenzoyl)cystineIBA
10/2014 - 10/2014
2taxaneIBA
03/2012 - 01/2008
2Goserelin (Zoladex)FDA Link
10/2011 - 02/2010
2VaccinesIBA
01/2011 - 05/2006
2AntigensIBA
01/2011 - 05/2006
2Proteins (Proteins, Gene)FDA Link
04/2008 - 11/2001
2Indicators and Reagents (Reagents)IBA
04/2007 - 01/2001
2DNA (Deoxyribonucleic Acid)IBA
07/2001 - 06/2000
2Drug CombinationsIBA
03/2001 - 03/2000
2GemcitabineFDA Link
02/2001 - 07/2000
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2022
1Cytotoxins (Cytolysins)IBA
03/2012
1eribulinFDA Link
03/2012
1130-nm albumin-bound paclitaxelIBA
03/2012
1ixabepilone (BMS 247550)FDA Link
03/2012
1Platinum Compounds (Compounds, Platinum)IBA
02/2012
1Alkylating AgentsIBA
02/2012
11-dodecylpyridoxal (PLD)IBA
02/2010
1liposomal doxorubicin (Doxil)FDA Link
02/2010
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2009
1SaltsIBA
05/2009
1Valproic Acid (Depakote)FDA LinkGeneric
01/2009
1Histone Deacetylase InhibitorsIBA
01/2009
1Bevacizumab (Avastin)FDA Link
11/2008
1Angiogenesis InhibitorsIBA
11/2008
1exemestane (Aromasin)FDA Link
07/2008

Therapy/Procedure

55Drug Therapy (Chemotherapy)
09/2017 - 01/2000
51Therapeutics
10/2022 - 11/2000
11Adjuvant Chemotherapy
09/2017 - 02/2000
9Radiotherapy
12/2017 - 08/2000
6Combination Drug Therapy (Combination Chemotherapy)
02/2012 - 01/2001
4ViFuP protocol
10/2003 - 01/2000
3Mastectomy (Mammectomy)
11/2012 - 04/2003
2Mammaplasty (Breast Reconstruction)
01/2020 - 03/2013
2Segmental Mastectomy (Lumpectomy)
12/2017 - 10/2003
2Neoadjuvant Therapy
04/2016 - 02/2015
2Catheters
05/2009 - 04/2004
2Central Venous Catheters
04/2004 - 01/2001
1Gastrectomy
04/2016
1Aftercare (After-Treatment)
05/2012
1Metronomic Administration
02/2010
1Orchiectomy (Orchidectomy)
12/2009
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2009